Our data demonstrate that both basal, constitutive noncanonical NF-κB activity, as well as induction of noncanonical NF-κB signaling by an endogenous cytokine, TWEAK, play critical roles in promoting glioma invasion. The gene discussed is TNFSF12; the disease is central nervous system cancer.